CCND1 Positive
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Ibrutinib Plus Rituximab and Lenalidomide in Treating Elderly Participants With Newly Diagnosed Mantle Cell Lymphoma (NCT03232307) | M.D. Anderson Cancer Center | 2019-07-01 |
| Bendamustine, Obinutuzumab, and Venetoclax in Patients With Untreated Mantle Cell Lymphoma (NCT03872180) | Emory University | 2019-04-11 |
| Ibrutinib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Older Patients With Newly Diagnosed Mantle Cell Lymphoma (NCT01880567) | M.D. Anderson Cancer Center | 2013-07-15 |
Track CCND1 Positive automatically
Every clearance here is in the API, with alerts when new ones post.